Electrocore LLC (ECOR) - Total Assets
Based on the latest financial reports, Electrocore LLC (ECOR) holds total assets worth $15.48 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore ECOR operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Electrocore LLC - Total Assets Trend (2016–2025)
This chart illustrates how Electrocore LLC's total assets have evolved over time, based on quarterly financial data. See ECOR book value for net asset value and shareholders' equity analysis.
Electrocore LLC - Asset Composition Analysis
Current Asset Composition (December 2025)
Electrocore LLC's total assets of $15.48 Million consist of 62.2% current assets and 37.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 37.7% |
| Accounts Receivable | $1.03 Million | 5.5% |
| Inventory | $1.63 Million | 8.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how Electrocore LLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ECOR company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Electrocore LLC's current assets represent 62.2% of total assets in 2025, a decrease from 81.3% in 2016.
- Cash Position: Cash and equivalents constituted 37.7% of total assets in 2025, down from 66.9% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 8.7% of total assets.
Electrocore LLC Competitors by Total Assets
Key competitors of Electrocore LLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
USA | $9.79 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
Electrocore LLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.02 | 1.52 | 4.41 |
| Quick Ratio | 0.86 | 1.30 | 4.23 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $213.00K | $4.12 Million | $19.65 Million |
Electrocore LLC - Advanced Valuation Insights
This section examines the relationship between Electrocore LLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 34.89 |
| Latest Market Cap to Assets Ratio | 2.70 |
| Asset Growth Rate (YoY) | -8.8% |
| Total Assets | $18.67 Million |
| Market Capitalization | $50.48 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Electrocore LLC's assets at a significant premium (2.70x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Electrocore LLC's assets decreased by 8.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Electrocore LLC (2016–2025)
The table below shows the annual total assets of Electrocore LLC from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $18.67 Million | -8.81% |
| 2024-12-31 | $20.47 Million | +27.13% |
| 2023-12-31 | $16.10 Million | -34.96% |
| 2022-12-31 | $24.76 Million | -42.20% |
| 2021-12-31 | $42.83 Million | +35.90% |
| 2020-12-31 | $31.52 Million | -11.12% |
| 2019-12-31 | $35.46 Million | -51.76% |
| 2018-12-31 | $73.50 Million | +87.35% |
| 2017-12-31 | $39.23 Million | +6207.34% |
| 2016-12-31 | $622.02K | -- |
About Electrocore LLC
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic… Read more